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Abstract.  Scatter factor/hepatocyte growth factor 
(SF/HGF) has potent motogenic, mitogenic, and mor- 
phogenetic activities on epithelial cells in vitro. The cell 
surface receptor for this factor was recently identified: 
it is the product of the c-met protooncogene, a 
receptor-type tyrosine kinase.  We report here the 
novel and distinct expression patterns of SF/HGF and 
its receptor during mouse development, which was de- 
termined by a combination of in situ hybridization and 
RNase protection experiments.  Predominantly,  we de- 
tect transcripts  of c-met in epithelial cells of various 
developing organs,  whereas the ligand is expressed in 
distinct mesenchymal cells in close vicinity. In addi- 
tion,  transient  SF/HGF and c-met expression is found 
at certain sites of muscle formation;  transient expres- 
sion of the c-met gene is also detected in developing 
motoneurons.  SF/HGF and the c-met receptor might 
thus play multiple developmental roles, most notably, 
mediate a signal given by mesenchyme and received 
by epithelial.  Mesenchymal signals are known to gov- 
ern differentiation and morphogenesis of many epithe- 
lia, but the molecular nature of the signals has re- 
mained poorly understood.  Therefore, the known 
biological activities of SF/HGF in vitro and the em- 
bryonal expression pattern reported here indicate that 
this mesenchymal factor can transmit morphogenetic 
signals in epithelial development and suggest a molec- 
ular mechanism for mesenchymal epithelial interac- 
tions. 
ECEPTOR-type tyrosine  kinases  and  their  specific 
ligands are essential components of intercellular  sig- 
naling  pathways used for the control of growth and 
differentiation  as  well  as  the  maintenance  of  normal 
homeostasis (Ullrich and Schlessinger,  1990).  In addition, 
evidence has accumulated that receptor tyrosine kinases can 
regulate morphogenic and differentiation  events during  de- 
velopment (Basler and  Hafen,  1988;  Chabot et al.,  1988; 
Geisler et al.,  1988; Sprenger et al.,  1989; Sonnenberg  et 
al.,  1991). The important role of receptor tyrosine kinases 
is also emphasized by the fact that many genes encoding such 
proteins were identified  by their oncogenic potential  when 
mutated (Yamamoto et al., 1983; Hampe et al., 1984; Neck- 
ameyer and Wang, 1985; Bargmann et al., 1986; Birchmeier 
et all., 1986; Martin-Zanca et al., 1986), among them c-met 
(Cooper et al., 1984). The met oncogene was originally  iso- 
lated by the use of the NIH3T3 transfection  assay (Blair et 
al.,  1982; Cooper et al.,  1984). It is the product of a chro- 
mosomal  rearrangement  which  fused  c-met  coding  se- 
quences of human  chromosome 7 to the translocated pro- 
moter region  (tpr) t locus of chromosome  1 (Park et al., 
1. Abbreviations  used in this paper: coxl, cytochrome oxidase;  SF/HGE 
scatter factor/hepatocyte growth factor; tpr, translocated promoter region. 
1986;  Dean et al.,  1987).  Similar  translocations  between 
c-met and tpr are frequently present in human gastric carci- 
nomas (Soman et al.,  1991). The c-met protooncogene en- 
codes a transmembrane  glycoprotein  of 190 kD,  which is 
cleaved posttranslationally  into two chains of 145 (/3) and 50 
kD (o0. The COOH-terminal part of the/~ chain contains the 
tyrosine kinase  domain  and  is  located  cytoplasmatically, 
whereas the NH2-terminal  part of the /3 and the entire  tx 
chain are exposed on the cell surface (Gonzatti-Haces  et al., 
1988; Giordano et al.,  1989). 
Recently,  the  ligand  of  the  c-met  receptor  has  been 
identified  (Bottaro et al.,  1991; Naldini  et al.,  1991a,b):  it 
is scatter factor/hepatocyte growth factor (SF/HGF), a pro- 
tein with  structural  similarities  to plasminogen.  SF/HGF 
contains four characteristic  kringle domains at the NH: ter- 
minus and a COOH-terminal, serine protease-like domain. 
However, amino acids in the active site which are essential 
for the catalytic activities  of serine proteases are altered  in 
SF/HGF (Miyazawa et al.,  1989;  Nakamura et al.,  1989; 
Weidner et al., 1991). Early studies on SF/HGF indicate that 
it acts in a paracrine fashion,  since many fibroblast cells de- 
rived from the mesenchyme secrete SF/HGF, whereas cells 
of epithelial  origin  respond  to  it  (Stoker and  Perryman, 
1985; Stoker et al., 1987; Gherardi et al., 1989). Two differ- 
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growth or movement, have been used to independently iso- 
late and molecularly characterize the factor (Gherardi et al., 
1989; Miyazawa et al., 1989; Nakamura et al., 1989; Zarne- 
gar and Michalopoulos, 1989;  Weidner et al.,  1990,  1991; 
Rosen et al.,  1990;  Rubin et al.,  1991). Besides mitogenic 
and motogenic activities, SF/HGF also increases invasive- 
ness of epithelial cells and can act as a cytostatic factor on 
various carcinoma cells (Weidner et al.,  1990;  Higashio et 
al., 1990; Shiota et al., 1992). In addition, a morphogenetic 
activity was recently discovered: MDCK epithelial cells are 
induced to form tubular structures when cultured in a three- 
dimensional collagen matrix in the presence  of SF/HGF 
(Montesano et al., 1991a,b; Weidner et al., 1993a).  Experi- 
ments with hybrid receptors demonstrate that the various bi- 
ological responses  to  SF/HGF are  all transduced by the 
c-met receptor tyrosine kinase (Weidner et al.,  1993b). 
To investigate the potential role of SF/HGF and its recep- 
tor in developmental processes, we have studied the expres- 
sion of the genes encoding these two proteins during mouse 
embryogenesis. By in situ hybridization analysis, we find a 
recurring pattern of expression during development of vari- 
ous epithelial organs: c-met transcripts in specific epithelial 
cells and expression of the SF/HGF gene in mesenchymal 
cells in close vicinity. This points towards a paracrine mode 
of SF/HGF action and indicates a function in mesenchymal 
epithelial interactions. Such interactions are known to gov- 
ern morphogenesis and differentiation of embryonal epithe- 
lia (Kratochwil, 1983).  In addition to this distinct pattern, 
we find transcripts of both genes also in neuronal cells and 
a transient expression in developing muscles. SF/HGF and 
the c-met receptor could thus mediate several effects during 
development, in particular a morphogenetic signal exchange 
between mesenchyme and epithelia. 
Materials and Methods 
cDNA Cloning and Analysis 
Mouse c-met and SF/HGF eDNA clones were isolated from a eDNA library 
synthesized from adult liver RNA (ML 1035b,  obtained from Clonetech, 
Heidelberg, Germany) by standard techniques (Maniatis et al., 1982).  For 
the screening, the entire coding sequence of the human c-met (Park et al., 
1987) and SF/HGF eDNA (Weidner et al., 1991) were used as probes. The 
isolated murine eDNA clones were characterized by sequence analysis. 
Comparison of the deduced amino acid sequences revealed 100% identity 
between our e-met isolate and the previously reported sequence for mouse 
c-met flyer et al., 1990;  Chan et al., 1988) and 90% identity between our 
murine isolate and the previously reported human SF/HGF eDNA (Weidner 
et al.,  1991). 
RNA Isolation and RNase Protection Assays 
Various tissues from embryonal or adult mice (strain NMRI, obtained from 
the Zentralinstitut fiir Versuehstierzucht, Hannover, FRG) were dissected 
and shock frozen in liquid nitrogen. For determination of the age of the em- 
bryos, the morning after vaginal plug formation was considered as day 0 
of embryonic development. Total RNA of the different tissues was prepared 
as described (Autfray and Rougeon,  1980). 
RNase protection experiments were performed essentially as described 
(Birchmeier et al.,  1987).  Probes were synthesized as run-off transcripts 
from  subclones of cDNAs  in  pBluescript  with  T7  RNA  polymerase. 
[32p]UTP  with a specific activity of 400 Ci/mmol for e-met and SF/HGF 
and of 0.8-40 Ci/mmol for coxI transcripts were used (0.8 Ci/mmol for the 
experiments shown in Fig. 2).  Probes were as follows: a 449-nucleotide 
transcript containing 126 nucleotides of  murine SF/HGF eDNA (mSF4, see 
Fig.  1) in antisense orientation (corresponding to position 467-593 in the 
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Figure 1. Schematic representation of SF/HGF and c-met cDNAs. 
The structure of SF/HGF (a) and c-met (b) cDNAs is shown. The 
translated sequences are indicated by boxes: the sequences encod- 
ing subdomains of SF/HGF, heavy (H) and light (L) chains and the 
four kringle domains (KI-K4) as well as subdomains in the c-met 
receptor, transmembrane domain (TM) and tyrosine specific pro- 
tein kinase domain (TK), are marked. The murine cDNA subclones 
used  for  in  situ  hybridization  (mSF1,  mSF2,  mSF3,  mMetl)  or 
RNase protection experiments (mSF4, mMet2) are indicated above. 
human eDNA sequence) and additional 323 nucleotides of plasmid derived 
sequences; a 471-nucleotide transcript containing 137 nueleotides of c-met 
eDNA (mMet2, see Fig. 1) in antisense orientation (position 3867--4004  in 
the murine eDNA) and 334 nucleotides of plasmid derived sequence; a 426 
nucleotide transcript containing 94 nucleotides of cytochrome oxidase I 
(coxI) sequence in antisense orientation (position 6624-6717 in mitoehon- 
drial DNA; Bibb et al.,  1981) and 332 nucleotides of plasmid derived se- 
quence. To control absolute amounts of RNA used for the RNase protection 
experiment, a mixture of c-met or SF/HGF probe (50,000 cpm) and coxI 
probe (4,000-50,000 cpm; 4,000 cpm for the experiment shown in Fig. 2) 
were hybridized overnight to 100/~g of RNA from various tissues, digested 
with 30 U of RNase T2 and analyzed on denaturing acrylamide gels. 
Table L  Expression of the SF/HGF and c-met Genes  in 
Various Murine Tissues 
Tissues  c-met  SF/HGF 
Kidney  El4  +  + 
El6  +  + 
El8  +  + 
P3  +  + 
adult  +  + 
Intestine  E 14  +  + 
El6  +  + 
El8  +  + 
Lung  El4  +  + 
El6  +  + 
El8  +  + 
Liver  adult  +  + 
Pancreas  El8  +  + 
Stomach  E 18  +  + 
Muscle  El8  +  + 
adult  +  - 
Total embryo  El0  +  + 
ES-cells  +  - 
RNA from the indicated sources was tested for SF/HGF and c-met expression 
by RNase  protection with specific anfisense probes. Expression of the coxl 
gene was used as internal  standard  (see Materials  and Methods). Expression 
levels were determined by comparing relative signal intensities obtained with 
RNA from various organs and adult liver RNA; (+) denotes a strong and (±) 
a very weak signal; (-) denotes the absence of a specifically protected band. 
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In situ hybridization was performed as described previously (Sonnenberg 
et al., 1991). Probes were as follows: murine c-met eDNA (mMetl, see Fig. 
1, corresponding to position 2298-3974  in the routine eDNA; Iyer et al., 
1990; Chan et al., 1988); murine SF/HGF eDNA (mSFI, mSF2, mSF3, see 
Fig. 1, corresponding to positions 75-465, 676-975, and 1104-2634 in the 
human  eDNA;  Weidner  et  al.,  1991); rat  myogenin eDNA  (position 
791-1486;  Sassoon et al.,  1989).  Antisense and sense RNA probes were 
synthesized as run-off  transcripts from subclones in pBluescript with either 
T7 or T3 RNA polymerase and 35S-labeled  UTP and CTP with a specific 
activity of >/1,000 Ci/mmol. The concentration of probes used for hybrid- 
ization was 100,000  cpm//zl for c-met and SF/HGF and 40,000 cpm//~l for 
myogenin.  No  specific signals were observed when transcripts in sense 
orientation were used for hybridization. 
Results 
To obtain homologous probes for the analysis of SF/HGF 
and c-met expression, murine cDNAs were isolated from a 
cDNA library made from adult liver RNA (see Materials and 
Methods); this organ is known to express both, c-met and 
SF/HGF (Noji et al.,  1990;  Di Renzo et al.,  1991; Schir- 
macher et al.,  1992).  The  structure of the cDNA clones 
selected for in situ hybridization and RNase protection anal- 
ysis are schematically shown in Fig.  1.  Transcripts of the 
SF/HGF gene are detected in a wide variety of embryonal 
tissues by RNase protection experiments (Table I and Fig. 2 
A). For example, embryonal lung, pancreas, kidney, and in- 
testine express the SF/HGF gene; the transcript levels are 
low in most of the tested organs (Fig. 2 A). Transcripts of 
the c-met gene can be identified by RNase protection in a 
wide variety of embryonal tissues (Table I), as observed pre- 
viously also by Northern hybridization (Iyer et al.,  1990). 
For example, embryonal lung, pancreas, salivary gland, kid- 
ney, intestine, and muscle express the c-met gene (Fig. 2 B). 
Transcripts of c-met are also found at various developmental 
stages, for example during the entire development of the kid- 
ney (Table I). 
To further analyze the expression patterns of  the c-met and 
SF/HGF  genes,  in  situ  hybridization  analysis  was  per- 
formed. This revealed that the genes for SF/HGF and the 
c-met receptor are expressed in mesenchymal and epithelial 
cells in a variety ofparenchymal  organs during development, 
which is shown in more detail below. 
Expression of c-met in Tubular Epithelia 
Lung, Pancreas, and Salivary Gland. Two major cell types, 
mesenchyme  and epithelia, contribute to the formation of  the 
lung,  pancreas,  and  submandibular  salivary  gland.  Out- 
growth of epithelial cells from the endoderm into mesen- 
chyme form the anlagen of these organs. All epithelia de- 
velop by further growth, branching, and differentiation from 
the first endodermal buds, a process which is dependent on 
mesenchymal signals (Fell and Grobstein,  1968;  Lawson, 
1972;  Masters,  1976).  We detect c-met transcripts in all of 
the developing epithelia of these organs (Fig. 3, A, C, E, and 
G, and data not shown). The presence of c-met specific tran- 
scripts was verified by RNase protection experiments (Fig. 
2).  The presence of transcripts  for SF/HGF was demon- 
strated in the surrounding mesenchyme and again could be 
confirmed by RNase protection experiments (Fig. 3, B, D, 
E  and H and Fig. 2). 
Meta-  and  Mesonephric  Kidney.  Development  of the 
metanephric kidney starts on day 11 of embryogenesis (Ell), 
when the ureter, a derivative of the Wolttian duct, reaches 
the nephrogenic mesenchyme. The ureter grows, branches, 
and differentiates in response to signals given by the mesen- 
chyme, and inductive signals given by the ureter lead to con- 
version of mesenchyme into new epithelia, which differenti- 
ate into proximal and distal tubules as well as glomeruli 
(Saxen,  1987; Ekblom,  1991). During the entire develop- 
Figure  2.  RNase  protec- 
tion analysis of SF/HGF and 
c-met  expression  in  embry- 
onal  mouse  tissues. Total 
RNA (100 #g) was analyzed 
by  hybridization  to  32p_ 
labeled  run-off  transcripts 
from murine SF/HGF (A) and 
c-met (B) cDNA as described 
in Materials and Methods. As 
an internal control, transcripts 
from coxl DNA in antisense 
orientation  were mixed into 
the  hybridization  reaction. 
End-labeled  Mspl cut pBR322 
DNA (M) and aliquots of the 
undigested probes (A, lane 1, 
coxI probe; lane 2,  SF/HGF 
probe; B, lane 1, coxl probe; 
lane 2, c-met probe) were run 
in parallel. Tissue sources of RNA used for hybridization in A and B: lanes 3, t-RNA from yeast; lanes 4, adult liver; lanes 5, embryonal 
(El8) intestine; lanes 6, embryonal (El8) lung; lanes 7, embryonal (El8) kidney; lanes 8, embryonal (El8) submandibular salivary gland; 
lanes 9, embryonal (El8) stomach; lanes 10, embryonal (El8) pancreas; lanes 11, embryonal (El8) muscle. The size of  the marker fragments 
are indicated in basepairs. The arrows indicate the undigested RNA probes (Isr/nGe: SF/HGF probe; Lox: coxI probe; I,,~,: c-met probe) 
and the specifically protected fragments (Psr/nor: protected fragment of SF/HGF probe; Pcox: protected fragment of coxl probe; P,~: pro- 
tected fragment of c-met probe). 
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analysis of SF/HGF and c-met 
expression in the  developing 
lung and pancreas. Sections of 
embryos on day 13 of  develop- 
ment were hybridized to c-met 
(A and E) or SF/HGF (B and 
F)  probes.  The  developing 
lung  is  shown in  dark_field 
(A  and  B)  or brightfield  (C 
and  D)  and  the  developing 
pancreas  in darkfield (E and 
F) and brightfield (G and H). 
Bars,  100/zm. 
ment of the kidney, we observe c-met transcripts in all tubu- 
lar epithelia, i.e., the ureter as well as proximal and distal 
tubules (Fig. 4, A, E, and G). In contrast, no c-met specific 
transcripts are not found in the glomerular epithelium (Fig. 
4 G). Concomitantly, SF/HGF expression is detected in the 
nephrogenic mesenchyme (Fig. 4 C). In early stages of kid- 
ney development, SF/HGF transcripts are present in the en- 
tire mesenchyme (Fig. 4  C); at later stages, transcripts are 
confined to the cortex of the kidney (data not shown). Since 
cells of all lineages located in the medulla correspond to 
later differentiation stages than cells in the cortex (Saxon, 
1987),  this  finding  indicates  that  mainly  undifferentiated 
mesenchyme  expresses  SF/HGE  RNase  protection  also 
demonstrated the presence of specific SF/HGF and c-met 
transcripts in the developing kidney (Fig. 2). During devel- 
opment and regression of the mesonephros, we observe c-met 
transcripts also in tubular epithelia and the Woltiian duct, 
whereas SF/HGF transcripts are present in the cortical re- 
gion of the nephrogenic mesenchyme (data not shown). 
Expression of c-met in Non-tubular Epithelia 
Digestive Tract. The intestinal anlagen are formed early in 
development,  and  consist  then  of  a  stratified,  poorly 
differentiated epithelium  which  is  surrounded  by  mesen- 
chymal cells.  Terminal differentiation is  initiated on E15, 
when the tight cellular contacts in the epithelial layers start 
to dissociate and mesenchymal cells are observed to invade 
the stratified epithelium. This process culminates in the for- 
mation of the single layered columnar epithelium of the villi 
The Jourrlal of Cell Biology,  Volume 123, 1993  226 Figure 4.  In sire hybridization analysis  of SF/HGF and c-met expression in the embryonal kidney.  Sections  through an embryo on day 
14 of development were hybridized to c-met (A, E, and G), SF/HGF (C) and control (D) probes.  Consecutive sections  of the developing 
kidney are shown in darktield (A, C, and D) and brightfield  (B). Higher magnification  (E, F, G, and H) of the developing  kidney. A c-met 
specific hybridization signal over a branching ureter bud (U) is indicated  by arrows (E and F). A S-shaped  body showing a strong c-met 
hybridization signal  in the developing  tubular (TE) but not the glomerular epithelia  (GE) is indicated  by arrows  (G and H).  Bars:  (B) 
100 pm; (F and H) 25 #m. 
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tation of  the intestine at differ- 
ent developmental  stages. The 
appearance of the murine in- 
testine at the indicated times 
in  development  is  depicted 
schematically. The  cuboidal 
cells  and  the  irregularly 
shaped cells represent epithe- 
lia and mesenchyme, respec- 
tively (modified after Mathan 
et al., 1976). 
(Fig. 5 and Mathan et al., 1976).  Transcripts for the c-met 
receptor are found in the epithelia of the intestinal anlagen 
and the villi, i.e., during the entire development of  the mouse 
(Fig. 6, A, B and E, F). However, the distribution of SF/HGF 
transcripts shows dynamic changes during development: we 
detect a faint positive hybridization signal on El4 which is 
located in a narrow layer of mesenchymal cells around the 
stratified epithelium (data not shown). When the cell con- 
tacts of the epithelia have loosened and the mesenchyme has 
started to invade the epithelial cell layers on El5, a strong 
hybridization signal is found in patches of  mesenchymal  cells 
in close vicinity to the epithelia (Fig. 6, B-D and H). These 
correspond to mesenchymal  ceils which are growing into the 
epithelial cell layers. On El7, when the one layered villi epi- 
thelium has already formed, specific transcripts are observed 
in patches of mesenchyme located close to the crypts (Fig. 
6, Fand G). 
Both the epithelia of the oesophagus and the stomach ex- 
press  transcripts  for the c-met receptor whereas the sur- 
rounding mesenchymal cells express the gene for SF/HGF 
(data not shown). Expression of both SF/HGF and c-met is 
also found in the liver starting on Ell. However, the resolu- 
tion of in situ hybridization with 3~S-labeled probes does, in 
general, not allow positive assignment of hybridization sig- 
nals to single, but rather to layers or groups of cells. There- 
fore, we were not able to identify the subpopulations of liver 
cells which express the genes for c-met or SF/HGE  The 
presence of SF/HGF and c-met specific transcripts in the de- 
veloping intestine, stomach and liver was also confirmed by 
RNase protection experiments (Fig. 2). 
Tooth.  Two cell types, ectomesenchymal and epithelial 
cells,  contribute  to  the  formation of the  tooth  (Slavkin, 
1974). The enamel organ formed by the epithelia is well de- 
veloped on El5 in the mouse. At this stage and also later in 
development, we observe transcripts for the c-met receptor 
in the outer enamel epithelium (Fig. 7, A and B). In the ad- 
vanced bell  stage,  SF/HGF transcripts  are  found in  the 
mesenchymal cells of the dental papillae (Fig. 7, B and C). 
Nasal Cavities. The nasal cavities develop from the olfac- 
tory pits, an ectodermal invagination, and differentiate into 
two functionally and histologically distinct units, an olfac- 
tory and a respiratory part (Adams, 1972). We demonstrate 
the presence of c-met transcripts in the entire epithelium of 
the developing nasal cavities (Fig. 7, D and E). In addition, 
c-met  transcripts  are  identified in  the  epithelium  of the 
vomeronasal organ (Fig. 7, D and E). With the appearance 
of Bowman's glands in the olfactory unit, c-met transcripts 
are detected in the epithelia of the glands (Fig. 7, D and E). 
In the developing olfactory unit, we identify c-met tran- 
scripts  in the entire multilayered olfactory epithelium on 
Eli. In contrast, on El5 the hybridization signal is confined 
to an apical position in the epithelium (data not shown). The 
nuclei and the cellular bodies of the ciliated support ceils are 
located apically which indicates that at later stages of devel- 
opment this epithelial cell type is responsible for the hybrid- 
ization  signal  observed.  Remarkably,  a  layer  of mesen- 
chymal cells in close vicinity to the epithelium of the nasal 
cavities expresses the ligand, SF/HGF. These mesenchymal 
cells are not distributed continuously around the entire epi- 
thelium, but are found only below the developing olfactory 
unit of the nasal cavities (Fig. 7, E and F). 
The expression pattern described above, epithelia express- 
ing c-met and mesenchyme in close vicinity expressing the 
ligand, is the prominent pattern observed during develop- 
ment of many parenchymal organs. However,  we identified 
additional sites of expression for c-met and SF/HGF in the 
embryo, which are shown below. 
Transient Expression of SF/HGF and c-met in 
Myogenic Cells 
Transcripts of the c-met gene are found in the somites start- 
ing on day 10 of embryogenesis. To identify the population 
of cells within the somites which express c-met, consecutive 
sections were hybridized to c-met and myogenin  probes. My- 
ogenin is known to be expressed specifically in cells of the 
myogenic lineage (Sassoon et al., 1989). Identical hybridiza- 
tion patterns were observed with both probes, indicating that 
the myotomal compartment of the somites expresses c-met 
(Fig. 8, A-C). During further development, we detect c-met 
specific transcripts also in intercostal regions, in the limb 
buds and the mandible. Hybridization of consecutive sec- 
tions with c-met and myogenin probes demonstrates also at 
these sites overlapping, but not absolutely identical patterns 
of expression (Fig. 8, E and G and data not shown). In addi- 
tion, c-met expression was found on El0 in the limb bud and 
thus before myogenin positive cells can be located at this site 
(Sassoon et al., 1989). Expression of c-met at sites of  muscle 
development is transient when analyzed by in situ hybridiza- 
tion. For example, transcripts of c-met are detected in the in- 
The Journal of Cell Biology,  Volume 123, 1993  228 Figure 6. In situ hybridization analysis of SF/HGF and c-met expression in the embryonal intestine. Consecutive sections through embryos 
on day 15 (A-C) and day 17 (E-G) of development were hybridized to c-met (A and E) and SF/HGF (C and G) probes. The developing 
intestine is shown in darkfield (A, C, E, and G) and brightfield (B and F). The arrows in B and C point towards patches of mesenchymal 
cells which express the SF/HGF gene. Higher magnification of a section from a E15 embryo hybridized to a SF/HGF probe (D and H), 
showing positive hybridization signals over mesenchymal cells (M) growing into the epithelial cell layers (E). Bars: (B and F) 100/~m; 
(H) 25/~m. Consecutive  sections in A, B, and C and E, F, and G are shown at identical magnifications. 
tercostal regions between Ell and E15, and in the limbs be- 
tween El0 and El5 (Table II). When analyzed by the more 
sensitive RNase protection method, low levels of c-met tran- 
scripts can be identified in RNA isolated from limb muscle 
of E18  embryos or adult mice (Table I). 
We also detect expression of SF/HGF in the limb buds and 
the mandible, but not at other sites of muscle formation like 
the myotome. Comparison of the spatial pattern of SF/HGF 
and myogenin hybridization signals in consecutive sections 
demonstrates that myogenic cells in the limb and mandible 
Sonnenberg ¢t al.  Scatter Factor and the c-met Receptor during Development  229 Figure 7. In situ hybridization analysis of  SF/HGF and c-met  expression in developing teeth and nasal cavities. Consecutive sections through 
embryos on day 18 of development were hybridized to c-met (A and D) and SF/HGF (C and F) probes.  A developing molar is shown 
in darkfield (A and C) and brightfield (B). Arrows point toward the outer enamel epithelium (OEE), the inner enamel epithelium (IEE), 
and the mesenchyme of the dental papilla (M).  The developing nasal cavity is shown in dark_field (D and F) and brightfield (E). Arrows 
point towards the vomeronasal organ (VO), Bowman's glands (BG), olfactory (OE),  and respiratory  (RE) epithelium.  Bars,  100 #m. 
express SF/HGF (Fig. 8, G and Hand data not shown). How- 
ever, the overlap between the hybridization signals obtained 
with  SF/HGF  and  myogenin  probes  is  not  complete. 
SF/HGF transcripts were already observed on El0 and thus 
before myogenin transcripts are detected in the limb buds. In 
addition, not all cell groups which express SF/HGF on Ell 
or E13 in the limb buds express myogenin, and not all myoge- 
nin positive groups of cells express SF/HGF (Fig. 8,  G and 
H). However, the overlap between the hybridization patterns 
observed with both probes appears to increase with the de- 
velopmental age of  the embryos. The time course of SF/HGF 
gene expression at sites of muscular development is again 
transient in nature when analyzed by in  situ hybridization 
(Table II); for example, expression is found in the developing 
limb between El0 and El5. When analyzed by RNase protec- 
tion, specific transcripts for SF/HGF can still be identified 
in RNA isolated from limb muscle of El8 embryos, but not 
of adult animals. 
The Journal of Cell Biology, Volume 123, 1993  230 Figure 8.  In situ hybridization analysis of the SF/HGF, c-met and myogenin expression at sites of muscular development. Consecutive 
cross sections of an Ell embryo shown in darkfield (,4, C, and D) and brightfield (B) hybridized to c-met (A), myogenin (C), and control 
probes (D) are depicted at the same magnification. Arrows point to the myotome (MY)  and motoneurons (MN).  Consecutive sections 
of the limb of an E13 embryo hybridized to e-met (E), myogenin (G), and SF/HGF (H) probes are shown in darkfield (E, G, and H) 
and brightfield (F) at the same magnification. Bars: (B)  100 ~m; (F) 200 ~m. 
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and c-met Expression at Sites of Muscle Formation and 
Development as Determined by In Situ Hybridization 
Somite  Axiale  muscle  Limb  Mandible 
met  SF/HGF  met  SF/HGF  met  SF/HGF  met  SF/HGF 
El0  +  -  -  -  +  +  -  - 
Ell  +  -  +  -  +  +  +  + 
El3  +  -  +  -  +  +  +  + 
El5  +  -  +  -  +  +  +  + 
El7  ........ 
Mouse embryos at different times of gestation were analyzed  for expression of 
SF/HGF and c-met  at sites of muscular development;  (+) denotes a strong, (+) 
a  weak,  and  (-)  no  detectable  signal  by  in  situ  hybridization. 
SF/HGF and c-met Expression in Neuronal Cell 7)~pes 
Transient c-met Expression in the Spinal Cord. Transcripts 
of the c-met gene are also observed in the embryonal spinal 
cord and confined there to the ventral horns (Fig. 9, A and 
B). This corresponds to the parts of the spinal cord where 
the nuclei and cellular bodies of  the motoneurons are located 
(Altman and Bayer, 1984).  Expression of c-met in the spinal 
cord is found only between Ell and El5. Onset of c-met ex- 
pression  correlates  therefore  with  the  "birthdate" of the 
motoneurons (Altman and Bayer,  1984). 
Telencephalon.  An  additional ueural  tissue,  the  telen- 
cephalon, expresses c-met and the SF/HGF gene during de- 
velopment. Four different cellular layers located in the ven- 
tricular,  subventricular,  intermediate,  and  marginal  zone 
form the telencephalon. Mitotic divisions take place in the 
ventricular zone, and give rise to cells which migrate out- 
wards to differentiate into elongated bipolar cells. Thus the 
Figure 9. In situ hybridization analysis of c-met expression in the 
spinal cord. Section through an embryo on day 11 of development 
hybridized to c-met in darkfield (A) and brighttield (B). The arrows 
point toward the ventral horns, where the nuclei of motoneurons 
(MN) are located, and toward the myotome (MY). Bar, 100/~m. 
inner layer contains the immature mitotic cells, while the 
marginal  zone  is  composed  of postmitotic,  differentiated 
cells  (Uylings  et  al.,  1990).  Expression  of  c-met  and 
SF/HGF can be observed in the telencephalon during prena- 
tal development, i.e., starting around El7. The c-met gene 
is then expressed in the marginal zone, while transcripts for 
SF/HGF  are  confined to  the  ventricular  layer  (data  not 
shown). 
Discussion 
We report here the expression analysis of the genes encoding 
the c-met receptor tyrosine kinase and its specific ligand, 
SF/HGE during mouse embryogenesis. A recurring pattern 
of expression is found during the development of epithelial 
organs: expression of the gene for c-met in certain epithelia, 
and specific transcripts for SF/HGF in mesenchymal cells in 
close vicinity. The observed distribution of specific tran- 
scripts indicates thus a paracrine mode of action for SF/HGF 
and its receptor during development of epithelial organs. 
Such a paracrine mode of action has been proposed origi- 
nally by Stoker and colleagues (Stoker et al.,  1987) and is 
consistent with the biological activities of SF/HGF in vitro: 
epithelial cells of diverse origins respond to the factor by var- 
ious biological activities like mitogenesis, movement, mor- 
phogenesis or growth arrest, whereas many fibroblasts and 
smooth muscle cell lines derived from the mesenchyme pro- 
duce SF/HGF (Stoker et al.,  1987; Gherardi et al.,  1989; 
Weidner et al., 1990; Rosen et al., 1990).  In addition, novel 
sites of  expression of  the two genes were identified: we detect 
a transient expression of c-met and SF/HGF during muscle 
development, and transient expression of the c-met receptor 
in the ventral horns of the spinal cord where the developing 
motoneurons are located. Expression of both receptor and 
ligand is also detected in the telencephalon. Besides a func- 
tion in mesenchymal epithelial interactions, SF/HGF and its 
receptor might thus also play a role in development of the 
brain  as  well  as  in  the  formation and/or  innervation  of 
muscle. 
SF/HGF and c-met in Development of 
Epithelial Organs 
During development of a variety of different organs, epithe- 
lial cells form complex branched tubular structures. In organ 
culture experiments,  it has  been  demonstrated that these 
morphogenetic processes  are  dependent on mesenchymal 
factors (Grobstein, 1967; Saxen, 1987).  It has recently also 
been found that epithelial MDCK cells grown in collagen 
gels  respond  to  exogenous SF/HGF by  the  formation of 
branched tubuli (Montesano et al., 1991b). We demonstrate 
here  that  during  mouse  embryogenesis, various  epithelia 
which form branching tubules, i.e. the epithelia of the lung, 
pancreas or salivary gland, do express c-met, while the sur- 
rounding mesenchyme expresses SF/HGF. In all these de- 
veloping organs, mesenchymal factors are known to be es- 
sential for morphogenesis and differentiation  of the epithelia 
(Grobstein and Cohen,  1965;  Cunha et al.,  1983;  Saxen, 
1987;  Ekblom,  1991). Similarly to the observed morpho- 
genie activity in vitro, SF/HGF might regulate such events 
during organogenesis in vivo. 
In the kidney, two types of tubular epithelia which express 
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proximal and distal tubuli. The ligand, SF/HGF is expressed 
in the nephrogenic mesenchyme. The branching epithelia of 
the ureter are again dependent on mesenchymal signals for 
proper morphogenesis (Saxen,  1987).  The epithelia of the 
tubuli as well as the glomeruli develop from the same pro- 
genitor cells, i.e., nephrogenic mesenchyme, which is con- 
verted into epithelia by inductive signals from the ureter 
(Saxen, 1987; Ekblom, 1991). Expression of c-met in these 
induced epithelia is restricted to proximal and distal tubules; 
no expression is found in the glomeruli or the precursors of 
all these cell types, the uninduced mesenchyme. Therefore, 
the observed expression pattern is incompatible with a role 
of c-met and SF/HGF in the induction of new kidney epithe- 
lia;  however,  it is consistent with the hypothesis that the 
c-met receptor and SF/HGF can play a general role in the 
formation of tubular structures from existing epithelia. 
We continuously observe transcripts for the c-met recep- 
tor in the intestinal epithelia during embryogenesis. How- 
ever,  expression  of the  ligand,  SF/HGF,  shows  dynamic 
changes concomitant with morphological reorganization and 
differentiation of the epithelium during villi formation. The 
epithelium of the intestinal anlagen is multilayered; during 
formation of  the villi, dissociation of  the tight epithelial com- 
plexes is observed and secondary lumina appear. At the same 
time, the mesenchymal cells invade the loosened stratified 
epithelium (Fig. 5 and Mathan et al.,  1976).  Concomitant 
with this morphological rearrangement, we observe strong 
expression of SF/HGF in patches of mesenchyme associated 
with cells invading the epithelium. Since a prominent activ- 
ity of SF/HGF on epithelial cells in vitro is the dissociation 
of adherent epithelial sheets (Stoker et al., 1987; Weidner et 
al., 1990), the observed loosening of the epithelial cell layer 
in the intestinal anlagen might be a direct consequence of 
SF/HGF production in the underlying mesenchyme. 
During development of the tooth, c-met  transcripts are 
found  in  the  outer  enamel  epithelium.  Transcripts  for 
SF/HGF are only detected in the advanced bell stage, i.e., 
starting around day 17 of development, and are located in the 
mesenchyme of the dental papilla. Since the outer enamel 
epithelium subsequently disappears, the SF/HGF mediated 
signal might not lead to  cell proliferation, but  rather to 
growth arrest and to degeneration of these particular cells. 
It is noteworthy that a cytostatic and degenerative activity of 
SF/HGF on particular epithelial target cells has been ob- 
served before (Higashio et al.,  1990;  Shiota et al.,  1992). 
In addition, a  prominent hybridization signal for c-met is 
found in epithelial cells of the nasal cavities during the entire 
development.  Again,  SF/HGF  expression  is  observed  in 
mesenchymal cells underlying the epithelium, which con- 
sists of two functionally distinct units, an olfactory and a re- 
spiratory part. SF/HGF transcripts are restricted to a layer 
of mesenchymal cells in the vicinity of the developing olfac- 
tory unit starting on E11 and thus before the appearance of 
differentiated cell types in the olfactory epithelium (Adams, 
1972).  A paracrine signal mediated by SF/HGF and c-met 
during development might thus play a role in the differentia- 
tion of this complex epithelium. 
The distribution of SF/HGF protein in the late rat embryo 
has  recently  been  determined  by  immunohistochemistry 
(Defrances et al., 1992). Surprisingly, the protein was found 
to be  located predominantly in the cytoplasm of various 
epithelia.  Yet,  SF/HGF mRNA is generally found in the 
mesenchymal but not the epithelial cell compartment. Since 
the high affinity receptor of SF/HGF is expressed on epithe- 
lia,  the  observed  location  of  SF/HGF  protein  in  the 
cytoplasm of such cells might represent internalized factor 
bound to the receptor. 
Molecular Nature of  Mesenchymal 
Epithelial Interactions 
Mesenchymal signals are  essential for differentiation and 
morphogenesis of epithelia, but their molecular nature is 
presently only poorly understood. In organ culture experi- 
ments,  it has  been  observed  that the  specificities of the 
mesenchymal signals  required  by different epithelia vary 
considerably. The pancreas is an extreme example for the 
nonspecificity of mesenchymal contributions to epithelial 
differentiation: pancreatic mesenchyme can be replaced by 
virtually every heterologous mesenchyme. In contrast, no 
heterologous mesenchyme which  can  support  growth  or 
morphogenesis of the ureter epithelium has been identified 
(Saxen,  1987).  Mesenchymal contributions  to  epithelial 
morphogenesis are therefore complex, and it is obvious that 
more than a single factor is involved (Grobstein, 1967). One 
such mesenchymal factor was recently characterized; it is 
epimorphin, a protein necessary for differentiation and mor- 
phogenesis of hair follicles and lung epithelia (Hirai et al., 
1992). 
Many genes for tyrosine kinase receptors were originally 
isolated as oncogenes and their protein products are there- 
fore commonly associated with mediating growth signals 
(Ullrich and Schlessinger, 1990). However, evidence has ac- 
cumulated recently that such receptors and their  specific 
ligands can also induce movement, differentiation or mor- 
phogenesis of epithelia depending on the exact target cells, 
i.e., they regulate processes which are essential in embryo- 
genesis. Several tyrosine kinase receptors with predominant 
or exclusive distribution on epithelial cells are known: (a) 
the c-met receptor, which can mediate mitogenic, motogenic 
and morphogenic signals (Gherardi,  1991; Weidner et al., 
1993b);  we show here that the c-met receptor is expressed 
in many embryonal epithelia, whereas the specific ligand is 
often produced in mesenchyme; (b) the c-ros receptor which 
is expressed transiently in epithelia of the kidney and intes- 
tine during development; we have suggested that this recep- 
tor  receives  mesenchymal  signals  during  organogenesis 
(Sonnenberg et al.,  1991); (c)  the c-neu receptor;  NDF/ 
heregulin, the putative ligand of c-neu, can induce differenti- 
ation of mammary carcinoma cells (Kokai et al., 1987; Press 
et al., 1990; Peles et al., 1992). NDF/heregulin is expressed 
in embryonal mesenchyme (Dirk Meyer and C. B., in prepa- 
ration). It is thus likely that some of the mesenchymal factors 
long  known  to  be  essential  for  appropriate  epithelial 
differentiation  during development, but whose molecular na- 
ture has remained elusive, will turn out to correspond to 
specific  ligands  for  receptor-type  tyrosine  kinases  (see 
Birchmeier et al., 1993; Birchmeier and Birchmeier, 1993). 
SF/HGF and c-met Expression in the Development 
of  Muscle 
Although all skeletal muscle derives from a common precur- 
sor pool, the myotome, at least two distinct types of skeletal 
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which derive from somite cells differentiating in situ within 
the somite and between the sclerotomal organization centers 
of the vertebrae; (b) the muscles of the limbs and visceral 
arches, which arise from cells that migrate away from so- 
mites and invade the lateral regions of the embryo, where 
they differentiate. Precursor ceils for the two types of muscle 
are located at distinct subregions of the somite (Ordahl and 
Le Douarin, 1992). We detect transient expression of c-met 
and SF/HGF in myogenic precursor cells. However, whereas 
c-met is expressed in both types of differentiating muscle, 
SF/HGF transcripts are confined to myogenic cells in the 
limbs and mandible. In the limb buds, prominent expression 
of both genes is found already on El0, i.e., before myogenic 
markers are expressed. In addition, we observed that the spa- 
tial distribution of SF/HGF, c-met and myogenin expressing 
cells is not completely overlapping even in later stages of de- 
velopment. It is therefore possible that SF/HGF and c-met 
are not only expressed in myogenic but also in other mesen- 
chymal  cells  in  the  limb  buds.  Alternatively,  myogenic 
precursors might exist which express the SF/HGF and c-met 
genes but not yet markers of myogenic differentiation like 
myogenin. 
Because of the partial overlap of c-met and SF/HGF ex- 
pression patterns in the limb buds, it is conceivable that an 
autocrine  signaling  system operates  at  distinct  sites  and 
times during muscle development. However, we use for our 
in  situ  hybridization  experiments  35S-labeled  antisense 
RNA probes. The resolution of this method allows assign- 
ment of  positive hybridization signals to groups or layers, but 
not to single cells.  Therefore, different subpopulations or 
differentiation stages  among  the  apparently  homogenous 
cells might exist, which express either c-met or SF/HGF. 
Expression of SF/HGF and c-met at sites of muscular de- 
velopment is transient in nature and found between El0 and 
E15. Interestingly, this transient expression correlates in time 
with the transient expression of the c-met receptor gene in 
developing motoneurons. Therefore, the c-met receptor and 
its ligand might play a role also in development and/or inner- 
vation of the muscle. 
Conclusion 
The  detailed  expression  analysis  of  c-met  and  SF/HGF 
reported here points towards multiple roles for the receptor 
and its ligand in embryogenesis. First and most notably, the 
receptor is expressed in epithelia, whereas transcripts for the 
ligand are found in distinct mesenchymal cells in close vicin- 
ity. This suggests that the receptor and its ligand mediate a 
signal exchange between mesenchyme and epithelia, a mech- 
anism long known to govern morphogenesis and differentia- 
tion of parenchymal organs. The second notable site for ex- 
pression  are  myogenic cells,  where  transcripts  for  both 
ligand and receptor are found at distinct times and sites of 
muscular  development.  Since  motoneurons  concurrently 
also express c-met, a role in muscle differentiation  and/or in- 
nervation is possible. Our results provide a basis for further 
analysis of receptor and ligand function, for example by ab- 
lating SF/HGF or c-met activity in muscle cell or organ 
culture experiments by adding antagonistic antibodies or 
peptides.  Alternatively,  genetic  approaches  like  targeted 
mutagenesis of the gene(s) encoding ligand or receptor, ec- 
topic overexpression of the ligand or expression of a domi- 
nant negative allele of c-met during development could lead 
to a further understanding of the developmental role of this 
signaling system. 
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